Add Row
Add Element
UPDATE
Add Element
  • Home
  • News Categories
    • Things to Do
    • Local Business News
    • Retire Well
    • Movers
    • Med + Tech
    • Neighborhoods
    • Military Moves
    • Local Loves
    • Explore NC
  • Business Directory
  • About The Resource Guides
  • Hometown Highlights
  • Hometown Hightlights Insider
    • JoAnn Stewart
Add Element
  • update
  • update
  • update
  • update
  • update
  • update
  • update
July 10.2025
3 Minutes Read

Diligent Robotics' New Leadership: A Game-Changer for Healthcare Tech Startups

Futuristic healthcare robot with digital display and arm.

Diligent Robotics Enhances Leadership with Cruise Alumni

Diligent Robotics is making significant moves to bolster its leadership team as it aims to scale its fleet of humanoid robots designed for hospitals and pharmacies. Based in Austin, Texas, the company recently announced the addition of Rashed Haq as Chief Technology Officer and Todd Brugger as Chief Operating Officer, both of whom previously held key roles at Cruise, General Motors’ self-driving division, which ceased operations earlier this year.

The Right Moves for Growth

CEO Andrea Thomaz expressed confidence in these appointments, emphasizing the right timing for such strategic leadership hires. With approximately 100 Moxi humanoid robots already deployed in healthcare settings to assist with non-patient facing tasks, Diligent is poised to enhance operational efficiencies and prepare for more dynamic scaling toward the end of this year.

Thomaz highlighted her enthusiasm for Haq’s expertise, particularly in AI development and real-world applications derived from autonomous vehicle technology. “Rashed's experience in translating AI from lab to life is invaluable,” she noted, as both leaders share a vision for integrating advanced technology in healthcare.

From Automotive to Healthcare: A Seamless Transition

Both Haq and Brugger perceive their roles at Diligent as a natural extension of their work at Cruise. They recognize that autonomous vehicles and robotics share fundamental principles, allowing them to apply their experience directly to healthcare robotics. Haq remarked, “Many companies are experiencing a form of 'vibe revenue’ with many early adopters due to the novelty of robots in clinical settings.” This insight highlights the importance of solidifying a stable user base as the technology matures.

What It Means for the Future of Healthcare Robotics

Diligent Robotics’ leadership changes may signify a transformative moment in healthcare technology. As healthcare continues to evolve, particularly in the wake of lessons learned during the pandemic, the demand for automation in hospitals and clinics has become essential. With influences from leaders who refined processes in high-tech environments like Cruise, Diligent is not just aiming to expand but to adapt its offerings to meet the growing needs within the healthcare sector.

This intersection between healthcare and technology reflects a burgeoning trend in the Research Triangle (RTP), where institutions like Duke University and UNC-Chapel Hill are pioneering advancements in biotechnology and clinical research. With partnerships and collaborations being cultivated, Diligent stands at the forefront of melding healthcare with robotics, appealing directly to tech startups and established firms in the RTP area.

Pathways for Professionals in Tech and Healthcare

For professionals contemplating career transitions within the THINGS to DO fields of healthcare, biotechnology, and tech startups, understanding these leadership narratives is essential. The recruitment of seasoned executives from a high-growth environment indicates the rising importance of strategic leadership in facilitating growth in complex sectors. Whether you are currently engaged in or contemplating a shift toward healthcare administration, there are valuable insights to glean from Diligent Robotics' moves. Those engaged in clinical research or educational pathways may find an abundance of opportunities as healthcare systems adapt to new technologies.

In planning your next career move within the RTP, consider how the integration of robotics and AI not only improves efficiency but presents a rich tapestry of opportunities across healthcare administration, pharmaceuticals, and academic medicine. In this evolving landscape, differentiating yourself will prove advantageous.

Med + Tech

127 Views

Write A Comment

*
*
Please complete the captcha to submit your comment.
Related Posts All Posts
03.19.2026

Empowering Emerging Healthcare Leaders: Navigating AI and Future Disruptions

Update Harnessing Technological Advancements in HealthcareAs the healthcare landscape undergoes rapid transformation, it's crucial for emerging leaders to embrace technology to enhance patient outcomes. Innovations in genomics, digital health, and artificial intelligence are making waves, creating tools that can change healthcare delivery fundamentally. Generative AI, particularly, presents unique opportunities to not only streamline processes but also improve health equity. The Dana-Farber Cancer Institute's study is a testament to this potential, showcasing that AI tools can outshine human performance in various healthcare-related tasks.The Ethical Landscape of AI in HealthcareHowever, the integration of such technologies isn't straightforward. Ethical and regulatory challenges pose significant hurdles that demand attention. Leaders must not only focus on the benefits of generative AI but also on its risks—like the possibility of bias or misinformation. Establishing a governance body is essential for steering policies and ensuring all voices within the organization are heard when implementing AI solutions.Preparing for a Disrupted FutureAs we face disruptions, fostering resilience among healthcare leaders is paramount. Encouraging open dialogue about new technologies, providing forums for employees, and engaging them in decision-making processes can create a culture of innovation. When leaders prioritize transparency in AI's implementation, they set a strong foundation for positive outcomes. Embracing these changes can strengthen organizations, making them more agile in the face of inevitable challenges that arise in the healthcare community.Conclusion: Stepping Into Healthcare's FutureThe future of healthcare is not only about adapting to new technologies. It involves empowering leaders to make informed decisions that collectively improve patient care. The lessons learned from the rapid advancements in AI should motivate us to explore further innovations. As we step into an era rich with possibilities, emerging health leaders have the opportunity to carve paths that align technological advancement with compassionate care.

03.13.2026

Gestala Raises $21M: A New Era for Non-Invasive Brain Tech

Update Gestala's Groundbreaking Approach to Brain-Computer Interfaces In the rapidly evolving field of brain-computer interfaces (BCIs), Chinese startup Gestala has launched a significant innovation by raising $21 million just two months post-launch. The investment reflects a growing excitement surrounding a new, non-invasive technology that employs ultrasound to interact with the brain. Unlike traditional BCIs that necessitate surgical implants, Gestala's ultrasound-based approach promises both safety and enhanced accessibility. Potential Impact on Healthcare Gestala aims to explore various medical applications, initially honing in on chronic pain management. Preliminary studies suggest that stimulating specific brain regions involved in pain processing may alleviate pain for extended periods without invasive measures. This could revolutionize how healthcare professionals treat chronic conditions while minimizing risks associated with surgery. Pioneering Technology for Broader Applications Beyond pain management, Gestala has ambitious plans to expand its ultrasound technology to address neurological and psychological conditions, including depression, PTSD, and Alzheimer's disease. The company’s goal is to develop a dual-function device that not only treats but also monitors brain activities, offering a more holistic approach to brain health. The Competitive Landscape Interestingly, Gestala is part of a rising tide of interest in BCIs, joining the ranks of other innovative startups like Merge Labs. Founded by Phoenix Peng, a former executive at NeuroXess, Gestala stands out due to its non-invasive methodology, which could make the technology more scalable and accessible. With such promising competitors emerging, the field of brain technology is evolving quickly, signaling an era where brain health solutions may soon be a standard part of clinical practice. Funding and Future Prospects This initial fundraising is just the beginning for Gestala. The funds will be used to accelerate research and development, recruit talent, and establish a manufacturing base. The ambitious timeline includes completing a prototype that showcases the potential of ultrasound technology before the end of 2026. For professionals in medical and research fields, Gestala’s rapid progress and focus on clinical applications warrant close attention as they might redefine established methods of patient care. Conclusion: Embracing Innovations in Healthcare The investment in Gestala underscores the mounting interest in leveraging cutting-edge technologies to improve health outcomes. For professionals in the healthcare, biotechnology, and tech sectors, staying informed about developments like those from Gestala is crucial. As the gap between technology and healthcare continues to close, understanding these innovations could empower your career, especially for those navigating transitions in established medical and research environments. For further insights into navigating your career in healthcare or exploring opportunities in the innovative landscape of the Research Triangle, connect with experts and resources that can guide you in this rapidly changing environment.

01.21.2026

How PraxisPro's $6M Seed Fund is Transforming Medical Sales Training with AI

Update The Rise of AI in Medical Sales CoachingPraxisPro's recent funding success signals a significant shift in the realm of medical sales training. The platform, launched by former sales reps who faced the challenges of insufficient training and fragmented coaching systems, aims to enhance the skills of medical sales representatives in a highly regulated environment. By leveraging AI and tailored communication training, PraxisPro aims to improve interactions between sales reps and healthcare providers, ultimately benefiting patient care.Addressing Common Challenges in Medical SalesSales representatives in the healthcare industry face unique challenges, including navigating complex regulatory frameworks and delivering compliant messages. According to a report from mple.ai, current pharma sales reps manage three times the product information than they did five years ago, requiring adaptive, context-sensitive training solutions. This pressure necessitates effective, on-demand practice tools, especially in a landscape where time with healthcare providers is severely limited. PraxisPro addresses these challenges by providing AI-driven simulations that replicate real-world interactions with healthcare professionals.The Competitive Edge Offered by AI ToolsAs noted in ZS's insights into AI-driven practice success, sales reps utilizing virtual training tools can experience substantial improvements in their effectiveness. For instance, such platforms can enhance sales readiness scores by 57% compared to traditional methods. PraxisPro employs small language models specifically tailored for medical contexts, allowing sales reps to engage in realistic conversations where they can practice compliance and respond to common objections. This approach positions them to establish trust faster and articulate complex medical data with confidence.Future of Sales Training: Personalization and ComplianceThe tools developed by PraxisPro are not just about practice; they are personalized learning journeys tailored to each representative's strengths and weaknesses. The feedback loop inherent in AI coaching fosters an environment that thrives on continuous improvement. In an age where healthcare expectations are at an all-time high, companies like PraxisPro provide strategic pathways for sales reps to build skills and prepare for challenging conversations with healthcare providers, ensuring compliance and ultimately improving patient outcomes.Investing in Developer Talent and R&DWith the funds raised in its $6M seed round, PraxisPro plans to expand its research and development capabilities. This injection of capital is crucial for refining their AI-driven platform and improving the user experience. As the market for biotechnology and medical products rapidly evolves, having a keen focus on R&D enables PraxisPro to remain competitive and innovative, preparing their users for an increasingly dynamic environment.Conclusion: The Importance of Adaptation in Medical SalesThe evolving landscape of medical sales necessitates a shift towards advanced training methodologies. With the incorporation of AI, platforms like PraxisPro present a unique solution to meet the industry's stringent demands, providing critical support to sales teams. For professionals in the medical, research, and tech sectors, understanding and adapting to these new sales strategies will be crucial in navigating today's healthcare environment effectively. Embracing AI-driven solutions not only enhances sales effectiveness but ensures that the conversation surrounding patient care remains a priority.

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*